Fundraising FoxCalliditas
Stockholm, SE · 3 known investors
Find your way into Calliditas
Sign up to see every warm intro you have to Calliditas
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Calliditas team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Calliditas is a biopharmaceutical company developing and commercializing treatments for renal and other conditions, including TARPEYO/Nefecon/Kinpeygo (budesonide) for primary IgA nephropathy and NOX inhibitor candidates such as setanaxib for fibrotic diseases and cancer. It works with commercial partners including Everest Medicines and STADA to bring its therapies to markets such as the US, UK, EU, and China.
Investors · 3
How we know: Industrifonden's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Sofinnova Partners's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · Not right? Tell us
Frequently asked questions
- What does Calliditas do?
- Calliditas is a biopharmaceutical company developing and commercializing treatments for renal and other conditions, including TARPEYO/Nefecon/Kinpeygo (budesonide) for primary IgA nephropathy and NOX inhibitor candidates such as setanaxib for fibrotic diseases and cancer. It works with commercial partners including Everest Medicines and STADA to bring its therapies to markets such as the US, UK, EU, and China.
- Who are Calliditas's investors?
- Calliditas's investors include Industrifonden, Sofinnova Partners, Kreos Capital.
- Where is Calliditas headquartered?
- Calliditas is headquartered in Stockholm, SE.